We identified mediator complex protein Med22 as a podocyte-enriched molecule and show that although Med22 is not needed for normal podocyte development, it plays a critical role in the maintenance of glomerular filtration barrier as mice with a mutant Med22 in podocytes develop a progressive renal disease. This evidence concerns the gene MED22 and kidney disorder.